Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 331.5 INR 2.6% Market Closed
Market Cap: 398B INR
Have any thoughts about
Biocon Ltd?
Write Note

EV/OCF
Enterprise Value to OCF

13.4
Current
30.9
Median
5.7
Industry
Lower than median
Higher than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
13.4
=
Enterprise Value
539.6B INR
/
Operating Cash Flow
40.4B INR
All Countries
Close
Market Cap EV/OCF
IN
Biocon Ltd
NSE:BIOCON
398B INR 13.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 317.7
US
Abbvie Inc
NYSE:ABBV
312.7B USD 22
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD -128.8
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 10.7
US
Epizyme Inc
F:EPE
94.1B EUR -470.5
AU
CSL Ltd
ASX:CSL
133.6B AUD 34.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 17.5
US
Seagen Inc
F:SGT
39.3B EUR -73.6
NL
argenx SE
XBRU:ARGX
34.8B EUR -128

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More